X-PAND Overview
- Headquarters
- Milan, IT
- Website
- www.xpand-project.eu
- Industry
- Biotechnology
- Employees
- 31
- Founded
- 2022
Keywords
About X-PAND
X-PAND is a four-year international multi-centric project funded with approximately 4 million euros by the European Union under the Horizon Europe – European Innovation Council program (GA n. 101070950). The ambitious goal of the project is to exploit innovative hematopoietic stem cell manipulation protocols in combination with a deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application. The X-PAND consortium is coordinated by San Raffaele Hospital in Milan, Italy (SR-Tiget institute) and sees the contribution of other international partners like the University of Navarra (Pamplona, Spain), the University Hospital Freiburg (Germany), the energy, environmental and technological research centre of Moncloa (Madrid, Spain), the Public Foundation Miguel Servet (Pamplona, Spain) and the Lausanne University Hospital (Switzerland).
Compare Similar Companies to X-PAND
Ikorganic
Farming
European Society of Gene and Cell Therapy
Research Services
Lawal
Law Practice
GIURI
Public Relations And Communications Services
T-FITNESS
Biotechnology Research
IMPACT EU project
Biotechnology Research
B-specific
Hospitals And Health Care
MIRACLE project
Higher Education
PAT4CGT Project
Biotechnology Research
Società Italiana di Terapia Genica e Cellulare(SITGEC)
Biotechnology Research